Moderna in Supply Agreement with Switzerland for Booster Vaccine

 Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a new supply agreement with the Swiss Federal Government for 7 million doses of booster vaccine in 2022, with an additional option for another 7 million doses for delivery during the second half of 2022 or first quarter of 2023. Purchase under this agreement is subject to regulatory approval of the booster vaccine candidate. Today’s announcement follows two earlier agreements between Switzerland and Moderna to supply a total of 13.5 million doses of the COVID-19 Vaccine Moderna. Swissmedic, the Swiss Agency for Therapeutic Products, authorized the COVID-19 Vaccine Moderna in Switzerland on January 12, 2021.

https://www.businesswire.com/news/home/20210506005563/en/Moderna-Announces-New-Supply-Agreement-with-Switzerland-for-7-Million-Booster-Vaccine-Doses-in-2022-and-Option-for-Additional-7-Million-Doses